BIOMAT Database Logo BIOMAT Database Logo

[Studies on the antihypertensive effect of beta-receptor-blocking agents]. 1968

H J Gilfrich, and K H Rahn, and F W Schmahl

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D004983 Ethanolamines AMINO ALCOHOLS containing the ETHANOLAMINE; (-NH2CH2CHOH) group and its derivatives. Aminoethanols
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013565 Sympatholytics Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. Sympathetic-Blocking Agents,Sympatholytic,Sympatholytic Agent,Sympatholytic Drug,Sympatholytic Agents,Sympatholytic Drugs,Sympatholytic Effect,Sympatholytic Effects,Agent, Sympatholytic,Agents, Sympathetic-Blocking,Agents, Sympatholytic,Drug, Sympatholytic,Drugs, Sympatholytic,Effect, Sympatholytic,Effects, Sympatholytic,Sympathetic Blocking Agents
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

H J Gilfrich, and K H Rahn, and F W Schmahl
[Comparative studies on beta-receptor-blocking agents].
January 1968, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
H J Gilfrich, and K H Rahn, and F W Schmahl
[Effect of beta receptor blocking agents on glucose utilization].
November 1968, Wiener medizinische Wochenschrift (1946),
H J Gilfrich, and K H Rahn, and F W Schmahl
The antihypertensive action of beta-adrenoceptor blocking agents.
January 1980, Archives internationales de pharmacodynamie et de therapie,
H J Gilfrich, and K H Rahn, and F W Schmahl
[Antihypertensive effect and adverse effects of treatment with beta-blocking agents].
November 1975, Lakartidningen,
H J Gilfrich, and K H Rahn, and F W Schmahl
The effect of various beta-receptor blocking agents on platelet aggregation.
March 1969, Experientia,
H J Gilfrich, and K H Rahn, and F W Schmahl
[Effect on the decrease in eosinophils of beta-receptor-blocking agents].
January 1969, Wiener medizinische Wochenschrift (1946),
H J Gilfrich, and K H Rahn, and F W Schmahl
Effect of adrenergic beta receptor blocking agents on cardiac output.
April 1970, Indian heart journal,
H J Gilfrich, and K H Rahn, and F W Schmahl
Ganglionic effect of beta adrenergic receptor blocking agents.
January 1980, Acta physiologica Academiae Scientiarum Hungaricae,
H J Gilfrich, and K H Rahn, and F W Schmahl
[Beta-receptor blocking agents].
January 1981, Krankenpflege Journal,
H J Gilfrich, and K H Rahn, and F W Schmahl
[Beta receptor blocking agents].
April 1967, Praxis,
Copied contents to your clipboard!